A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mass.
Epistemonikos ID: 16ab74c30ea9eefb5e19ea7c07bcf2b593cfe7d8
First added on: Sep 01, 2024